跳至主要内容
临床试验/ACTRN12618002020268
ACTRN12618002020268已完成未知

A text message intervention to support women’s self-efficacy and physical and mental health outcomes after breast cancer treatments (EMPOWER-SMS): a randomized controlled trial

The University of Sydney, Westmead Clinical School0 个研究点目标入组 160 人开始时间: 2018年12月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Patients will be eligible to participate if they are female, >18 years old; diagnosed with Breast Cancer; have completed breast cancer treatments (surgery, chemotherapy and/or radiation therapy) within the past 18 months (although can still be on endocrine treatment); own an operational mobile phone, capable of sending and receiving text messages; and provide written informed consent.

排除标准

  • Patients will be excluded if they: are already participating in a text message-based study; have been diagnosed with distant metastatic breast cancer or cannot comply with study requirements (i.e. does not want to return for a follow-up visit).

研究者

发起方
The University of Sydney, Westmead Clinical School

相似试验

A text message program to support women’s physical... | 临床试验